500 patients66,097 observations150 daysLIVE
eligible for NP-02 · confidence ≥ 70%

Patients needing attention

Synthetic demo data
Clear
21
patients · eligible for NP-02 · confidence ≥ 70%
Create intervention
Most common reason
GI intolerance
Most effective previous action
GI-04
Nutritional protocol
Estimated addressable population
10
eligible for GI-04, confidence ≥ 70%
Predicted persistence gain
+17%
LLIFE OS insight · why this cohort goes where it goes
grounded · add an LLM key for prose

eligible for NP-02 · confidence ≥ 70%: 21 patients, mean day 134. 33% have deteriorating tolerance, 86% unstable GI, 100% carry ≥60% discontinuation risk; mean GI 66, adherence 56%. Dominant clusters: EC-03 57%, LT 43%.

Shared biology: Low microbial diversity 81%, FUT2 non-secretor 76%, Low butyrate capacity 67%, Baseline state S14 62%, Cluster EC-03 (high response / high intolerance) 57%, Adherence < 60% 57%, IL6 high-expression variant 48%. Dietary detractors: fat in 95%, histamine in 76%, lactose in 67%.

What worked: GI-04 improved 60% of 5.

No learned rules apply yet; run learning after the first campaign results.

PatientDayBaselineGIToleranceGI scoreDiscontinuationCluster
P-03067150S14UnstableDeteriorating7296%EC-03
P-03078139S14UnstableUnstable7196%EC-03
P-03177140S10UnstableStable8196%LT
P-03375139S14UnstableDeteriorating7196%EC-03
P-03427107S14UnstableFavorable6896%EC-03
P-03488146S14UnstableImproving7696%EC-03
P-03345140S14UnstableStable6995%EC-03
P-03058140S14UnstableStable6793%EC-03
P-03301109S12UnstableFavorable7091%LT
P-03459145S14ImprovingImproving5688%EC-03
P-03034138S14UnstableStable7885%EC-03
P-03153143S08UnstableDeteriorating6780%LT
P-03473116S01UnstableDeteriorating6179%LT
P-03419146S14ImprovingFavorable5078%EC-03
P-03475120S14UnstableDeteriorating6878%LT
P-03253147S15UnstableStable6975%LT
P-03361150S14UnstableImproving6375%EC-03
P-03303128S16UnstableStable6171%LT
P-03273119S15UnstableDeteriorating5868%LT
P-03124138S14ImprovingStable4964%EC-03
P-03227121S05UnstableDeteriorating6262%LT